Rockwell Medical (RMTI) Current Deferred Revenue (2010 - 2024)
Rockwell Medical's (RMTI) quarterly Current Deferred Revenue came in at $46000.0 in Q4 2024, little changed YoY from $46000.0 in Q1 2024, and down 90.55% on a QoQ basis from $487000.0 in Q3 2024.
Rockwell Medical (RMTI) Current Deferred Revenue (2010 - 2024) Analysis & Trends
Rockwell Medical (RMTI) has 15 years of Current Deferred Revenue data on file, last reported at $46000.0 in Q4 2024.
- Quarterly Current Deferred Revenue changed 0.0% year-over-year to $46000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $46000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $46000.0, changed 0.0% from the prior year.
- Current Deferred Revenue eased to $46000.0 in Q4 2024, from $487000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $11.6 million in Q1 2020 to a low of $46000.0 in Q4 2023.
- A 5-year average of $2.6 million and a median of $2.2 million in 2021 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 1346.0% — and 2023, when it slumped 98.94%.
- Tracing RMTI's Current Deferred Revenue over 5 years: stood at $2.2 million in 2020, then jumped by 275.03% to $8.2 million in 2021, then plunged by 46.9% to $4.3 million in 2022, then tumbled by 98.94% to $46000.0 in 2023, then changed by 0.0% to $46000.0 in 2024.
- The last three Current Deferred Revenue figures came in at $46000.0 (Q4 2024), $487000.0 (Q3 2024), and $46000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 487,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 510,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 533,000.00 |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 259,000.00 |
| Dec 31, 2022 | 4.33 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 8.16 Mn |
| Sep 30, 2021 | 2.18 Mn |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 2.18 Mn |
| Sep 30, 2020 | 2.18 Mn |
| Jun 30, 2020 | 2.17 Mn |
| Mar 31, 2020 | 11.63 Mn |